UroGen settles JELMYTO patent litigation with Teva

Go back to UroGen settles JELMYTO patent litigation with Teva
(NASDAQ: URGN) Delayed: 33.57 +0.76 (2.32%)
Previous Close $32.81    52 Week High
Open $33.45    52 Week Low
Day High $33.79    P/E N/A 
Day Low $32.21    EPS
Volume 847,100